AASLD 2019: Direct-Acting Antivirals + Ezetimibe May Open the Door to More Viable Organs for Transplantation
The combination may prevent or cure hepatitis C infection in transplant recipients of infected donors.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.